Pierre de Sarrau Partner
Laboratoires SERB (“SERB”) is an independent speciality pharmaceutical group headquartered in Brussels, Belgium. SERB manages a well-diversified portfolio of branded, generic medicines across four main therapeutic areas: Emergency Care, Diagnostic Colouring, Neurology and Endocrinology. It has built its portfolio through strategic acquisitions and targeted developments, completing 16 acquisitions over the last 12 years.
SERB focuses on the registration, pharmacovigilance and sale of niche drugs to hospitals, clinics, healthcare authorities and governmental organisations. Its products are distributed in over 80 countries through a direct presence in six European countries and a strong network of distributors.
Visit: SERB website